Fromentin A - Search Results

1

Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C.

Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, Droin N, Hamai A, Pequignot M, Hammann A, Moutet M, Fromentin A, Kroemer G, Solary E, Garrido C. Schmitt E, et al. Among authors: fromentin a. Cancer Res. 2004 Apr 15;64(8):2705-11. doi: 10.1158/0008-5472.can-03-2475. Cancer Res. 2004. PMID: 15087383

2

HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.

Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, Mehlen P. Garrido C, et al. Among authors: fromentin a. Cancer Res. 1997 Jul 1;57(13):2661-7. Cancer Res. 1997. PMID: 9205074

3

Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.

Garrido C, Fromentin A, Bonnotte B, Favre N, Moutet M, Arrigo AP, Mehlen P, Solary E. Garrido C, et al. Among authors: fromentin a. Cancer Res. 1998 Dec 1;58(23):5495-9. Cancer Res. 1998. PMID: 9850085

4

Flt3 ligand lessens the growth of tumors obtained after colon cancer cell injection in rats but does not restore tumor-suppressed dendritic cell function.

Favre-Felix N, Martin M, Maraskovsky E, Fromentin A, Moutet M, Solary E, Martin F, Bonnotte B. Favre-Felix N, et al. Among authors: fromentin a. Int J Cancer. 2000 Jun 15;86(6):827-34. doi: 10.1002/(sici)1097-0215(20000615)86:6<827::aid-ijc11>3.0.co;2-r. Int J Cancer. 2000. PMID: 10842197

5

Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells.

Gurbuxani S, Bruey JM, Fromentin A, Larmonier N, Parcellier A, Jäättelä M, Martin F, Solary E, Garrido C. Gurbuxani S, et al. Among authors: fromentin a. Oncogene. 2001 Nov 8;20(51):7478-85. doi: 10.1038/sj.onc.1204948. Oncogene. 2001. PMID: 11709719

6

An atypical caspase-independent death pathway for an immunogenic cancer cell line.

Larmonier N, Billerey C, Rébé C, Parcellier A, Moutet M, Fromentin A, Kroemer G, Garrido C, Solary E, Martin F, Bonnotte B. Larmonier N, et al. Among authors: fromentin a. Oncogene. 2002 Sep 5;21(39):6091-100. doi: 10.1038/sj.onc.1205738. Oncogene. 2002. PMID: 12203121

7

Freshly isolated bone marrow cells induce death of various carcinoma cell lines.

Larmonier N, Ghiringhelli F, Larmonier CB, Moutet M, Fromentin A, Baulot E, Solary E, Bonnotte B, Martin F. Larmonier N, et al. Among authors: fromentin a. Int J Cancer. 2003 Dec 10;107(5):747-56. doi: 10.1002/ijc.11463. Int J Cancer. 2003. PMID: 14566824

8

Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27.

Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo AP, Chauffert B. Garrido C, et al. Among authors: fromentin a. Eur J Biochem. 1996 May 1;237(3):653-9. doi: 10.1111/j.1432-1033.1996.0653p.x. Eur J Biochem. 1996. PMID: 8647109 Free article.

9

FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection.

Favre N, Bonnotte B, Droin N, Fromentin A, Solary E, Martin F. Favre N, et al. Among authors: fromentin a. Int J Cancer. 1999 Jul 30;82(3):359-67. doi: 10.1002/(sici)1097-0215(19990730)82:3<359::aid-ijc9>3.0.co;2-k. Int J Cancer. 1999. PMID: 10399953

10

HSP27 inhibits cytochrome c-dependent activation of procaspase-9.

Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. Garrido C, et al. Among authors: fromentin a. FASEB J. 1999 Nov;13(14):2061-70. doi: 10.1096/fasebj.13.14.2061. FASEB J. 1999. PMID: 10544189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters